SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12221158
Source:
http://linkedlifedata.com/resource/pubmed/id/12221158
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0025815
,
umls-concept:C1113695
,
umls-concept:C1280500
,
umls-concept:C1333400
pubmed:issue
5
pubmed:dateCreated
2002-9-10
pubmed:abstractText
To determine the effect of IV methylprednisolone (IVMP) on brain fraction volume (BFV), contrast-enhancing (CE) lesions, and white matter lesion load (WMLL) in patients with relapsing-remitting MS treated for acute exacerbations.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta
,
http://linkedlifedata.com/resource/pubmed/chemical/Methylprednisolone
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon beta 1a
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon beta-1b
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0028-3878
pubmed:author
pubmed-author:BartC ACA
,
pubmed-author:FrankJ AJA
,
pubmed-author:HowardTT
,
pubmed-author:LewinB DBD
,
pubmed-author:McFarlandH FHF
,
pubmed-author:RaoA BAB
,
pubmed-author:RichertNN
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
688-94
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12221158-Adjuvants, Immunologic
,
pubmed-meshheading:12221158-Adult
,
pubmed-meshheading:12221158-Anti-Inflammatory Agents
,
pubmed-meshheading:12221158-Atrophy
,
pubmed-meshheading:12221158-Brain
,
pubmed-meshheading:12221158-Cross-Over Studies
,
pubmed-meshheading:12221158-Female
,
pubmed-meshheading:12221158-Humans
,
pubmed-meshheading:12221158-Interferon-beta
,
pubmed-meshheading:12221158-Magnetic Resonance Imaging
,
pubmed-meshheading:12221158-Male
,
pubmed-meshheading:12221158-Methylprednisolone
,
pubmed-meshheading:12221158-Middle Aged
,
pubmed-meshheading:12221158-Multiple Sclerosis, Relapsing-Remitting
pubmed:year
2002
pubmed:articleTitle
Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b.
pubmed:affiliation
Laboratory of Diagnostic Radiology Research, Clinical Center, NIH, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial